Advanced Search
Contact | Corporate | Help

Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma

Sponsors:
  • Duke University
  • Hoffmann-La Roche
  • Sanofi-Aventis
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
XAGastric
  • Esophageal Neoplasms
  • Stomach Neoplasms
  • Neoplasm Metastasis
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: capecitabine (Xeloda), oxaliplatin and bevacizumab (Avastin)
Enrollment:
37

Additional information about NCT00447330.


SourceSolution © 2008-2012